Organizations Filed Purposes:
frontal lobe of the brain and may extend back to the temporal lobe. FTD is the second most common early-onset dementia after Alzheimer's disease.
The Organization's primary mission is to help find a cure for Frontotemporal dementia (FTD). The Bluefield Project was founded by a family group whose lives have been directly impacted by FTD. FTD is a clinical syndrome caused by degeneration of the [continued on page 2]
The Bluefield Project is an effort to find a treatment or cure for frontotemporal dementia (FTD) by funding FTD-related research. By privately funding basic, translational and clinical FTD-related research, the donor group that established The Bluefield Project has significantly increased the number of labs studying FTD. The Consortium for Frontotemporal Dementia Research, funded in part by The Bluefield Project, applies a business model to research by incentivizing the sharing of data and reagents, thereby accelerating discovery. FTD encompasses a group of complex neurodegenerative diseases characterized by progressive deterioration of the frontotemporal lobes and resultant loss of decision-making abilities and control of behavior, emotion, and language.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
Name | Title | Hours Per Week | Total Salary |
Rodney Pearlman Phd | President | 40 | $373,000 |
Anne Alward | VP Corp Dev | 40 | $176,600 |
Alexandra Nicholson | Assoc Dir Rsrch | 40 | $115,625 |
Karen Chen Phd | Director | 4 | $0 |
Williamson Bradford Md | Director | 4 | $0 |
Bruce Miller Md | Director | 4 | $0 |
Robert V Farese Jr Md | Director | 4 | $0 |
Ian Massey Phd | Director | 4 | $0 |
Roy Richards Jr | Director | 4 | $0 |
Christopher Donohoe | Secty/Treasurer | 4 | $0 |
Robin Richards Donohoe | Board Chair | 4 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202033199349301653_public.xml